Cargando…
Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex
Emerging antiviral resistant strains of influenza A virus are greatly limiting the therapies available to stop aggressive infections. Genome changes that confer resistance to the two classes of approved antivirals have been identified in circulating influenza A viruses. It is only a matter of time b...
Autores principales: | Davis, Alicia M, Chabolla, Bryan J, Newcomb, Laura L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180549/ https://www.ncbi.nlm.nih.gov/pubmed/25228366 http://dx.doi.org/10.1186/1743-422X-11-167 |
Ejemplares similares
-
Nuclear localized Influenza nucleoprotein N-terminal deletion mutant is deficient in functional vRNP formation
por: Sanchez, Abel, et al.
Publicado: (2014) -
A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity
por: Cubitt, Beatrice, et al.
Publicado: (2020) -
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
por: Hou, Lingxin, et al.
Publicado: (2022) -
Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
por: Götz, Veronika, et al.
Publicado: (2016) -
Corrigendum: Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
por: Götz, Veronika, et al.
Publicado: (2016)